# Nt-proBNP Guided Primary Prevention of CV Events in Diabetic Patients

> **NCT00562952** · PHASE2,PHASE3 · COMPLETED · sponsor: **Medical University of Vienna** · enrollment: 300 (actual)

## Conditions studied

- Diabetes Mellitus
- Heart Failure
- Coronary Artery Disease

## Interventions

- **DRUG:** Telmisartan, Bisoprolol
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00562952
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2012-05-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00562952

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00562952, "Nt-proBNP Guided Primary Prevention of CV Events in Diabetic Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00562952. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*